Apple signs deal with LQMT

Day Trades

Sold 25% of my position in LQMT at $.39,  I started buying LQMT at $.16 so I got a fast double. Today LQMT was up 25% while the market was down 300+ points.  This stock has more room to run although I recommend using a tight stop loss if you are currently in it.  On the week I finished up over 50% in LQMT.

Day trades

Bought LQMT at $.231 , this is a speculative microcap stock that has a deal in the works with Apple and various companies that use bulk amorphous alloys and liquid metal.  

BitCoin Burn

BitCoin Burn- the chart speaks for itself

Possibly the biggest Pyramid Scheme ever?

Trades

Bought VIX 05/21/2014 18.00 C at $2.40, bought a small position in LQMT at $.165 as Apple continues to take interest by placing patents that involve LQMT and their super strong metal. 

Kona

Buy KONA Grill, KONA



Austin

ICAD

I am pretty heavily invested in ICAD at around $9 a share. Watch this one. iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy that enable healthcare professionals and radiologists to identify pathologies and pinpoint cancer earlier. It offers Axxent eBx system, which is used for the treatment of early stage breast cancer, endometrial cancer, and skin cancer, as well as for the treatment of other cancers or conditions where radiation therapy is indicated. It also provides computer-aided detection (CAD) solutions for digital and film-based mammography systems, including SecondLook systems that detects and identifies masses and micro-calcifications; and PowerLook Advanced Mammography Platform, a computer server residing on a customer’s network that receives patient studies from the imaging modality, performs CAD analysis, and sends the CAD results to PACS and/or review workstations. In addition, the company offers image analysis and workflow solutions in MRI imaging comprising SpectraLook for breast, VividLook for prostate, and OmniLook for other organs; and VersaVue Enterprise, a review and reporting solution, which provides visual and quantitative depictions of the movement of contrast agent through a lesion. Further, it provides VeraLook that supports the detection of colonic polyps in conjunction with CT Colonography; and the TotalLook MammoAdvantage system, a mammography specific digitizer. The company sells its products to hospitals, ambulatory care centers, and free standing radiation oncology facilities. The company sells its products directly, as well as through various original equipment manufacturer partners, distributors, and resellers worldwide. iCAD, Inc. has a strategic alliance with DermEbx. The company was founded in 1984 and is headquartered in Nashua, New Hampshire.